Laura L. Holman

1.1k total citations
60 papers, 635 citations indexed

About

Laura L. Holman is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Oncology. According to data from OpenAlex, Laura L. Holman has authored 60 papers receiving a total of 635 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Obstetrics and Gynecology, 26 papers in Reproductive Medicine and 17 papers in Oncology. Recurrent topics in Laura L. Holman's work include Endometrial and Cervical Cancer Treatments (27 papers), Ovarian cancer diagnosis and treatment (25 papers) and Cervical Cancer and HPV Research (9 papers). Laura L. Holman is often cited by papers focused on Endometrial and Cervical Cancer Treatments (27 papers), Ovarian cancer diagnosis and treatment (25 papers) and Cervical Cancer and HPV Research (9 papers). Laura L. Holman collaborates with scholars based in United States, Canada and South Korea. Laura L. Holman's co-authors include Karen H. Lu, Charlotte C. Sun, Kathleen N. Moore, Michael Frumovitz, Charles F. Levenback, Koji Matsuo, Sue Friedman, Molly S. Daniels, Mark F. Munsell and Shitanshu Uppal and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Scientific Reports.

In The Last Decade

Laura L. Holman

54 papers receiving 628 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura L. Holman United States 14 353 325 156 135 97 60 635
Tracie Miles United Kingdom 10 402 1.1× 262 0.8× 181 1.2× 94 0.7× 37 0.4× 17 611
Charlotte Gerd Hannibal Denmark 18 266 0.8× 551 1.7× 172 1.1× 92 0.7× 72 0.7× 34 842
Elizabeth Suh‐Burgmann United States 14 304 0.9× 310 1.0× 74 0.5× 92 0.7× 56 0.6× 37 546
Astrid Baalbergen Netherlands 14 312 0.9× 212 0.7× 113 0.7× 240 1.8× 117 1.2× 24 601
Amy L. Gross United States 10 152 0.4× 289 0.9× 154 1.0× 59 0.4× 68 0.7× 14 538
Tugan Beşe Türkiye 16 489 1.4× 486 1.5× 94 0.6× 85 0.6× 41 0.4× 59 771
Fuat Demirkıran Türkiye 16 451 1.3× 436 1.3× 132 0.8× 118 0.9× 34 0.4× 76 775
Ioannis Biliatis United Kingdom 13 331 0.9× 268 0.8× 84 0.5× 139 1.0× 28 0.3× 29 519
M J E Mourits Netherlands 8 215 0.6× 175 0.5× 143 0.9× 174 1.3× 185 1.9× 10 551
Simona Moroni Italy 16 229 0.6× 328 1.0× 180 1.2× 55 0.4× 162 1.7× 20 665

Countries citing papers authored by Laura L. Holman

Since Specialization
Citations

This map shows the geographic impact of Laura L. Holman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura L. Holman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura L. Holman more than expected).

Fields of papers citing papers by Laura L. Holman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura L. Holman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura L. Holman. The network helps show where Laura L. Holman may publish in the future.

Co-authorship network of co-authors of Laura L. Holman

This figure shows the co-authorship network connecting the top 25 collaborators of Laura L. Holman. A scholar is included among the top collaborators of Laura L. Holman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura L. Holman. Laura L. Holman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Duska, Linda, Gina R. Petroni, Premal H. Thaker, et al.. (2025). Update on safety and feasibility of the combination of pembrolizumab and pelvic chemoradiation in locally advanced cervical cancer. Cancer. 131(4). e35757–e35757. 3 indexed citations
2.
Brock, Pamela, M. N. Webster, Sandya Liyanarachchi, et al.. (2025). Germline POT1 Variants in a Pan-Cancer Cohort. JCO Precision Oncology. 9(9). e2400946–e2400946.
3.
Carter, Jeanne, Helen Huang, Bradley J. Monk, et al.. (2025). Evaluation of physical function and quality of life before and after nonradical surgical therapy for stage IA1 and IA2-IB1 cervical cancer (GOG-0278). Gynecologic Oncology. 195. 50–58. 1 indexed citations
4.
Klopp, Ann H., Danielle Enserro, Matthew A. Powell, et al.. (2024). Radiation Therapy With or Without Cisplatin for Local Recurrences of Endometrial Cancer: Results From an NRG Oncology/GOG Prospective Randomized Multicenter Clinical Trial. Journal of Clinical Oncology. 42(20). 2425–2435. 10 indexed citations
5.
Duska, Linda, Laura L. Holman, Erin K. Crane, et al.. (2023). A randomized phase II study of chemoradiation and pembrolizumab for locally advanced cervical cancer (005). Gynecologic Oncology. 176. S5–S5. 2 indexed citations
6.
Han, Chae Young, Karen H. Lu, Deepak G. Bedi, et al.. (2023). The Normal Risk Ovarian Screening Study (NROSS): Twenty-one year update.. Journal of Clinical Oncology. 41(16_suppl). 5522–5522. 2 indexed citations
7.
8.
Arend, Rebecca C., Bradley J. Monk, Ronnie Shapira‐Frommer, et al.. (2023). Randomized controlled phase III trial of weekly paclitaxel ± ofranergene obadenovec (VB-111) for platinum-resistant ovarian cancer (OVAL Study/GOG 3018).. Journal of Clinical Oncology. 41(16_suppl). 5505–5505. 2 indexed citations
9.
10.
11.
12.
Prendergast, Emily, Laura L. Holman, Tiffany Lai, et al.. (2019). Comprehensive genomic profiling of recurrent endometrial cancer: Implications for selection of systemic therapy. Gynecologic Oncology. 154(3). 461–466. 26 indexed citations
13.
Moore, Kathleen N., Sara K. Vesely, Koji Matsuo, et al.. (2019). Incorporation of whole pelvic radiation into treatment of stage IVB cervical cancer: A novel treatment strategy. Gynecologic Oncology. 156(1). 100–106. 18 indexed citations
14.
Allen, Richard A., et al.. (2016). Adenocarcinoma of the cervix involving the fallopian tube mucosa: report of a case. Diagnostic Pathology. 11(1). 77–77. 9 indexed citations
15.
Holman, Laura L., Yu Ren, & Shannon N. Westin. (2015). Status epilepticus associated with platinum chemotherapy in a patient with cervical cancer: a case report. BMC Cancer. 15(1). 728–728. 6 indexed citations
16.
Holman, Laura L., Sue Friedman, Molly S. Daniels, Charlotte C. Sun, & Karen H. Lu. (2014). Acceptability of prophylactic salpingectomy with delayed oophorectomy as risk-reducing surgery among BRCA mutation carriers. Gynecologic Oncology. 133(2). 283–286. 55 indexed citations
17.
Holman, Laura L., David A. Iglesias, Pamela T. Soliman, et al.. (2013). Long-term survival in advanced-stage uterine papillary serous carcinoma.. Journal of Clinical Oncology. 31(15_suppl). 5596–5596. 1 indexed citations
18.
Holman, Laura L., Sue Friedman, Molly S. Daniels, Charlotte C. Sun, & K.H. Lu. (2013). Acceptability of salpingectomy alone as risk-reducing surgery for BRCA mutation carriers. Gynecologic Oncology. 130(1). e104–e104. 2 indexed citations
19.
Holman, Laura L., Karen H. Lu, Robert C. Bast, et al.. (2013). Risk perception, worry, and test acceptance in average-risk women who undergo ovarian cancer screening. American Journal of Obstetrics and Gynecology. 210(3). 257.e1–257.e6. 7 indexed citations
20.
Holman, Laura L. & Karen H. Lu. (2012). Genetic Risk and Gynecologic Cancers. Hematology/Oncology Clinics of North America. 26(1). 13–29. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tracie Miles Breakdown of academic impact, for papers by Charlotte Gerd Hannibal Breakdown of academic impact, for papers by Elizabeth Suh‐Burgmann Breakdown of academic impact, for papers by Astrid Baalbergen Breakdown of academic impact, for papers by Amy L. Gross Breakdown of academic impact, for papers by Tugan Beşe Breakdown of academic impact, for papers by Fuat Demirkıran Breakdown of academic impact, for papers by Ioannis Biliatis Breakdown of academic impact, for papers by M J E Mourits Breakdown of academic impact, for papers by Simona Moroni
Rankless by CCL
2026